Intranasal drug delivery: opportunities and toxicologic challenges during drug development

LA Keller, O Merkel, A Popp - Drug delivery and translational research, 2022 - Springer
Over the past 10 years, the interest in intranasal drug delivery in pharmaceutical R&D has
increased. This review article summarises information on intranasal administration for local …

[HTML][HTML] Myricetin: A review of the most recent research

X Song, L Tan, M Wang, C Ren, C Guo, B Yang… - Biomedicine & …, 2021 - Elsevier
Myricetin (MYR) is a flavonoid compound widely found in many natural plants including
bayberry. So far, MYR has been proven to have multiple biological functions and it is a …

Insulin and insulin resistance in Alzheimer's disease

A Sędzikowska, L Szablewski - International journal of molecular sciences, 2021 - mdpi.com
Insulin plays a range of roles as an anabolic hormone in peripheral tissues. It regulates
glucose metabolism, stimulates glucose transport into cells and suppresses hepatic glucose …

Tau suppresses microtubule-regulated pancreatic insulin secretion

SP Mangiafico, QZ Tuo, XL Li, Y Liu… - Molecular …, 2023 - nature.com
Tau protein is implicated in the pathogenesis of Alzheimer's disease (AD) and other
tauopathies, but its physiological function is in debate. Mostly explored in the brain, tau is …

Dysfunctional glucose metabolism in Alzheimer's disease onset and potential pharmacological interventions

V Kumar, SH Kim, K Bishayee - International Journal of Molecular …, 2022 - mdpi.com
Alzheimer's disease (AD) is the most common age-related dementia. The alteration in
metabolic characteristics determines the prognosis. Patients at risk show reduced glucose …

[HTML][HTML] Mechanism of metformin regulation in central nervous system: Progression and future perspectives

G Cao, T Gong, Y Du, Y Wang, T Ge, J Liu - Biomedicine & …, 2022 - Elsevier
Metformin as a first-line drug for type 2 diabetes mellitus (T2DM) treatment is widely studied.
Metformin can reduce liver glucose output and improve insulin resistance. Recent evidence …

[HTML][HTML] AdipoRon induces AMPK activation and ameliorates Alzheimer's like pathologies and associated cognitive impairment in APP/PS1 mice

M Khandelwal, K Manglani, P Upadhyay, M Azad… - Neurobiology of …, 2022 - Elsevier
Alzheimer's disease (AD) is a progressive devastating neurodegenerative disorder
characterized by extracellular amyloid beta (Aβ 42) plaque formation, hyperphosphorylation …

Obstructive sleep apnea and cognitive decline: a review of potential vulnerability and protective factors

J Legault, C Thompson, MÈ Martineau-Dussault… - Brain Sciences, 2021 - mdpi.com
Around 40% of dementia risk is attributable to modifiable risk factors such as physical
inactivity, hypertension, diabetes and obesity. Recently, sleep disorders, including …

Roles of vascular risk factors in the pathogenesis of dementia

S Takeda, H Rakugi, R Morishita - Hypertension Research, 2020 - nature.com
The number of people with dementia is rapidly growing along with the aging of society and
is becoming a social issue worldwide. The results of recent clinical and basic studies have …

Diagnostic accuracy of blood-based biomarker panels: a systematic review

A Hardy-Sosa, K León-Arcia… - Frontiers in aging …, 2022 - frontiersin.org
Background Because of high prevalence of Alzheimer's disease (AD) in low-and middle-
income countries (LMICs), there is an urgent need for inexpensive and minimally invasive …